Day One Bio Day One Bio

Now FDA approved
in the U.S.

Ready to make an impact.

We are working hard to bring novel targeted therapies to children with brain tumors and potentially others who can benefit.


To request a printed copy (or copies) of the whitepaper booklet, complete this form:

Please enter a number from 1 to 5.
Mailing Address(Required)
This field is for validation purposes and should be left unchanged.

You are now leaving the Day One Biopharmaceuticals Corporate Website

You will now be redirected to the requested website. Please confirm that you want to proceed.